SYnAbs monoclonal antibodies

Wednesday, 21 October, 2020 | Supplied by: Sapphire Bioscience

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Cayman Chemical Natural Products Screening Library

Cayman Chemical's Natural Products Screening Library consists of 22 plates and contains...

AdipoGen Life Sciences DYRK inhibitors

Leucettinibs provide research tools and potential leads for further optimisation towards...

GroPep Bioreagents IGF-1 Family Proteins

IGF-1 proteins are available in different sizes, and all GroPep Bioreagents are freeze-dried and...

Content from other channels on our network

Manufacturing production returns to expansion: S&P Global

Filling the logic solver gap

Orica eliminates one million tonnes of GHG emissions

IO-Link and the role of the IO-Link Master

Fortescue endorses global movement for a fossil fuel treaty

Business must continue to lead on addressing climate change

CSIRO projection sees 4000 new jobs in HEM sector

Novel approach to desalination tech could help to ease water scarcity

Heavy mine site electric vehicles to get supercharged

Sydney Water trial at Cascade Water Filtration Plant reduces PFAS levels

Artificial 'nose' can sniff out damaged fruit and spoiled meat

Leading fresh produce industry advocates join IFPA ANZ board

Meat alternatives preferred if much cheaper than the real thing

Keeping it cool for Spanish soup making

Genetic predisposition plays role in bitter coffee taste

  • All content Copyright © 2025 Westwick-Farrow Pty Ltd